Paion AG
XETRA:PA8
Paion AG
XETRA:PA8
Price:
0.25
EUR
-30.56%
Market Closed
Market Cap:
€1.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Paion AG
XETRA:PA8
|
DE |
|
V
|
Vinacomin Northern Coal Trading JSC
VN:TMB
|
VN |
|
Novatti Group Ltd
ASX:NOV
|
AU |
|
AVIT Ltd
SZSE:300264
|
CN |
|
Changgao Electric Group Co Ltd
SZSE:002452
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PA8.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PA8
Multiples-Based Value
Not Available
Multiples Across Competitors
PA8 Competitors Multiples
Paion AG Competitors
Paion AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Paion AG
XETRA:PA8
|
1.8m EUR | 0.1 | -3.1 | 4.9 | 10.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.4B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.5B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.8B USD | 5.8 | 20.1 | 12.6 | 15.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.1B USD | 9.3 | 28.3 | 21.3 | 22.2 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.3B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR | 12.5 | 40.2 | 43.6 | 44.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.1B AUD | 2.9 | 32.4 | 10.9 | 13.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
